> top > docs > PMC:7784830 > spans > 16111-16981 > annotations

PMC:7784830 / 16111-16981 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
254 120-128 Disease denotes COVID-19 MESH:C000657245
255 409-417 Disease denotes COVID-19 MESH:C000657245
256 480-488 Disease denotes COVID-19 MESH:C000657245
257 489-499 Disease denotes infections MESH:D007239
258 634-657 Disease denotes corona virus infections MESH:C000657245
259 837-845 Disease denotes COVID-19 MESH:C000657245

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T124 0-279 Sentence denotes Chinese National Health Commission announced, dated 14 April 2020, three patented Chinese herbal drugs for treatment of COVID-19 which include namely: ‘Lianhuaqingwen capsules and Jinhuaqinggan granules for mild conditions, and Xuebijing (injectable) for severe conditions’ [80].
T125 280-418 Sentence denotes Luo et al. carried out an excellent review on Chinese herbal medicines that have the strong potential for usage in prevention of COVID-19.
T126 419-505 Sentence denotes They have also reported the highly used herbs for preventing COVID-19 infections [81].
T127 506-727 Sentence denotes A Korean company by name, Biostandard Inc, reported usage of fermented Isatidis Radix Extract and claim to be effective against corona virus infections and they have protected the same by a Korean patent application [82].
T128 728-870 Sentence denotes Few other companies/academic institutions that have patent protected herbal extracts effective in preventing COVID-19 are provided in Table 3.